• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,266.30 -123.15
(-0.30%)
Dow Jones
5,680.75 -4.19
(-0.07%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
85.39 0.69
(0.81%)
EUR-INR
96.28 0.21
(0.22%)
GBP-INR
113.48 0.52
(0.46%)
JPY-INR
0.59 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
64.25
1079.71
EPS(TTM)
Face Value()
Div & Yield %
28.52
10
0
 

Aerpace Industries reports standalone net loss of Rs 0.68 crore in the September 2024 quarter
Nov 12,2024
Net Loss of Aerpace Industries reported to Rs 0.68 crore in the quarter ended September 2024 as against net loss of Rs 0.25 crore during the previous quarter ended September 2023. Sales rose 30.00% to Rs 0.39 crore in the quarter ended September 2024 as against Rs 0.30 crore during the previous quarter ended September 2023.

ParticularsQuarter Ended
Sep. 2024Sep. 2023% Var.
Sales0.390.30 30
OPM %-217.95-56.67 -
PBDT-0.60-0.13 -362
PBT-0.68-0.21 -224
NP-0.68-0.25 -172